相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials
Wei Zheng et al.
PHARMACOPSYCHIATRY (2019)
Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects
Helene Speyer et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2019)
The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials
Davy Vancampfort et al.
WORLD PSYCHIATRY (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis
Pierre Ellul et al.
CNS DRUGS (2018)
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)
Brendon Stubbs et al.
EUROPEAN PSYCHIATRY (2018)
Effects of dosage and dosing frequency on the efficacy and safety of high-dose metformin in Japanese patients with type 2 diabetes mellitus
Kousei Kanto et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
Russell L. McLaughlin et al.
NATURE COMMUNICATIONS (2017)
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness
Scott B. Teasdale et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Concurrent Validity of a Self-Reported Physical Activity Vital Sign Questionnaire With Adult Primary Care Patients
Trever J. Ball et al.
PREVENTING CHRONIC DISEASE (2016)
Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
Dan J. Siskind et al.
PLOS ONE (2016)
The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses
Clazien Bouwmans et al.
VALUE IN HEALTH (2015)
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2015)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
David M. Nathan
LANCET DIABETES & ENDOCRINOLOGY (2015)
Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission
Peter Manu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Maarten Bak et al.
PLOS ONE (2014)
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
David Preiss et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial
Cenk Tek et al.
BMC PSYCHIATRY (2013)
Weight Change From 3-Year Observational Data
Chris J. Bushe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Weight gain in antipsychotic-naive patients: a review and meta-analysis
I. Tarricone et al.
PSYCHOLOGICAL MEDICINE (2010)
The Physical Activity Vital Sign: A Primary Care Tool to Guide Counseling for Obesity
Jessica L. J. Greenwood et al.
JOURNAL OF PHYSICAL ACTIVITY & HEALTH (2010)
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
M. De Hert et al.
EUROPEAN PSYCHIATRY (2009)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?
Sukanta Saha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance
OD Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Evidence that three dimensions of psychosis have a distribution in the general population
NC Stefanis et al.
PSYCHOLOGICAL MEDICINE (2002)
Dropout rates in randomised antipsychotic drug trials
K Wahlbeck et al.
PSYCHOPHARMACOLOGY (2001)
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects
E Mannucci et al.
DIABETES CARE (2001)
分享论文
